Dr. Minji Kim

CBO at Mineralys Therapeutics

Speaker

Minji Kim, Ph.D. has served as our Chief Business Officer since January 2024. Prior to joining Mineralys, she was Chief Business Officer at Affamed Therapeutics and General Manager at Affamed Digital, leading global partnerships and cross-border operations. Previously, Dr. Kim was Head of Business Development and Alliance Management at Jounce Therapeutics, Vice President of Corporate and Business Development at Curis, Inc and served on the Global Oncology Business Development & Licensing group at Hoffmann-La Roche. Throughout her industry career, she constantly delivered transformative and profitable impact by executing strategic transactions, raising non-dilutive funding, expanding pipeline, and establishing corporate development and R&D strategies. Before she entered the biopharma industry, she was Instructor in Neurology at Harvard Medical School. Dr. Kim obtained her Ph.D. in Seoul National University in South Korea and MBA in Yale School of Management. She currently serves as an independent board member of SK Biopharmaceuticals, a global commercial-stage life science company.